Gilder Gagnon Howe & CO LLC Renalytix PLC Transaction History

Gilder Gagnon Howe & CO LLC

$7.59 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.26 - $1.47 $30,769 - $173,964	-118,343 Reduced 13.46%	761,108 $654,000
Q4 2023 Feb 14, 2024	SELL	$0.33 - $1.61 $43,702 - $213,217	-132,433 Reduced 13.09%	879,451 $342,000
Q3 2023 Nov 14, 2023	SELL	$1.51 - $4.01 $23,951 - $63,606	-15,862 Reduced 1.54%	1,011,884 $1.62 Million
Q2 2023 Aug 14, 2023	BUY	$2.0 - $2.92 $93,620 - $136,685	46,810 Added 4.77%	1,027,746 $3 Million
Q1 2023 May 15, 2023	SELL	$1.93 - $3.72 $54,323 - $104,706	-28,147 Reduced 2.79%	980,936 $2.37 Million
Q4 2022 Feb 14, 2023	SELL	$1.06 - $2.21 $187,386 - $390,683	-176,780 Reduced 14.91%	1,009,083 $1.89 Million
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.78 $443,180 - $1.04 Million	-372,421 Reduced 23.9%	1,185,863 $1.52 Million
Q2 2022 Aug 15, 2022	SELL	$2.45 - $7.81 $3.1 Million - $9.88 Million	-1,264,425 Reduced 44.79%	1,558,284 $3.82 Million
Q1 2022 May 16, 2022	SELL	$5.88 - $15.9 $1.5 Million - $4.05 Million	-255,017 Reduced 8.29%	2,822,709 $19.5 Million
Q4 2021 Feb 14, 2022	SELL	$13.43 - $27.4 $2 Million - $4.07 Million	-148,686 Reduced 4.61%	3,077,726 $48.9 Million
Q3 2021 Nov 15, 2021	SELL	$17.91 - $34.78 $727,253 - $1.41 Million	-40,606 Reduced 1.24%	3,226,412 $64.7 Million
Q2 2021 Aug 16, 2021	BUY	$23.56 - $34.25 $5.79 Million - $8.42 Million	245,701 Added 8.13%	3,267,018 $101 Million
Q1 2021 May 17, 2021	BUY	$15.25 - $31.13 $7.18 Million - $14.6 Million	470,577 Added 18.45%	3,021,317 $77.5 Million
Q4 2020 Feb 16, 2021	BUY	$10.69 - $16.0 $547,413 - $819,328	51,208 Added 2.05%	2,550,740 $40.8 Million
Q3 2020 Nov 16, 2020	BUY	$10.18 - $17.3 $25.4 Million - $43.2 Million	2,499,532 New	2,499,532 $30.5 Million

Others Institutions Holding RNLX

# of Institutions

Shares Held

3.72M

Call Options Held

Put Options Held

View Full List

About Renalytix plc

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $7.86M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

More about RNLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account